Low impact
JPMorgan raised Regeneron Pharmaceuticals price target to $900 from $850.
FirstSquawk07/31, 12:37 PM
Related assets
Coming up for REGN
Explore next
Latest REGN news
Bloomberg07/31, 06:40 PM
ZeroHedge07/30, 06:54 PM
LiveSquawk07/30, 05:44 PM